🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Stay Connected with Tyra Biosciences! We're bringing exciting updates for the #achondroplasia community. Follow us for the latest on clinical trials, research & ways to get involved! 🔗 Facebook: facebook.com/tyrabiosciences 🔗 Instagram: @tyrabiosciences #RareDisease

Tyra Biosciences is joining #ACMGMtg25 March 18-22, 2025. Join us for the best four days of everything about #medicalgenetics! Catch up with us at Booth #838 in the Exhibit Hall!

Attending #ACMGMtg25? Come say hello to the Tyra Biosciences team and learn about our work to advance research and innovation for the achondroplasia community!

Tyra Biosciences is excited to be at #ACMG2025 here in LA, engaging with researchers, scientists, & dedicated patient advocates like Kristen from the The Little Legs Big Heart Foundation. If you're attending, visit us at Booth #838—we’d love to connect! #TeamTyra

Thank you, #ACMGmtg2025, for the incredible opportunity to exhibit and debut Tyra’s BEACH301 clinical trial for children ages 3-10 with achondroplasia. We had engaging conversations & sat in on insightful scientific discussions and presentations. tyra.bio/#optin

Recently, we visited the achondroplasia study team at Rare Disease Research in Atlanta. The team at Tyra Biosciences is excited to collaborate on advancing the BEACH301 study for children living with achondroplasia.

Now Enrolling: BEACH301 Clinical Trial In partnership with Tyra Biosciences, Rare Disease Research (RDR) is committed to advancing research and providing access to a new clinical trial for eligible children with achondroplasia. Learn more at achondroplasia.bio

We were honored to welcome Victoria Garcia - better known as "Nurse Vic" - a leader in the #achondroplasia community, to Rare Disease Research. Partnerships like these help deepen our understanding of community perspectives & strengthen our commitment to developing therapies that matter.

Team Tyra is proud to partner with Bladder Cancer Advocacy Network & sponsor the Walk to End Bladder Cancer this weekend in San Diego! These events help increase awareness about Bladder Cancer & provide essential support to thousands of individuals living with the disease. #BCAN25

Thank you to the organizers of Bladder Cancer Advocacy Network for including Team Tyra Biosciences in the Walk to End Bladder Cancer! Our team had a great time and we look forward to advancing our science for #bladdercancer, with the goal to improve patient outcomes. See you next year! #BCAN25

Today, Tyra Biosciences reported financial results for the first quarter of 2025 and recent highlights.  More details here: prnewswire.com/news-releases/…

📣 Attending ESPE & ESE 2025? Tyra Biosciences is excited to exhibit at the Joint ESPE & ESE Congress in Copenhagen! We’re advancing research in achondroplasia through our BEACH301 study. 📍 Booth #E26 🗓 May 10–13 🔗 Learn more or opt in here: tyra.bio/#optin

💬 We loved connecting with clinicians and advocacy leaders at ESPE & ESE 2025—thank you for stopping by the Tyra Biosciences booth! Couldn’t make it? You can still learn about our work in achondroplasia research, including our BEACH301 study. 🔗 tyra.bio/#optin

📣 Heading to PES 2025? Tyra Biosciences is excited to be there! Stop by our booth to learn more about our work. 🗓 May 15–18 #PES2025 #TyraBiosciences

We’re live at PES 2025! Visit Tyra Biosciences at Booth #115 to learn about our research in achondroplasia. #PES2025 #TyraBiosciences

Thank you for connecting with Tyra Biosciences at PES 2025! If you missed us, learn more about our research here: tyra.bio/#optin #PES2025 #TyraBiosciences